(Z)-5-(3'-methoxybenzylidene)-3-methyl-2-thioxothiazolidin-4-one | 1133954-01-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (Z)-5-(3'-methoxybenzylidene)-3-methyl-2-thioxothiazolidin-4-one
• 英文别名: (5Z)-5-(3-methoxybenzylidene)-3-methyl-2-thioxo-1,3-thiazolidin-4-one；(5Z)-5-[(3-methoxyphenyl)methylidene]-3-methyl-2-sulfanylidene-1,3-thiazolidin-4-one
• CAS: 1133954-01-4
• 化学式: C₁₂H₁₁NO₂S₂
• 分子量: 265.357
• InChiKey: OSEQJMTWKHYMAC-YFHOEESVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  86.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  3-甲基罗丹宁 、 3-甲氧基苯甲醛 在 溶剂黄146 、 三乙胺 作用下， 以 乙酸乙酯 为溶剂， 反应 3.0h， 以79%的产率得到(Z)-5-(3'-methoxybenzylidene)-3-methyl-2-thioxothiazolidin-4-one
  参考文献：
  名称：

  Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2

  摘要：

  The identification, synthesis and evaluation of a series of rhodanine and thiazolidin-2,4-dione derivatives as selective inhibitors of human arylamine N-acetyltransferase 1 and mouse arylamine N-acetyltransferase 2 is described. The most potent inhibitors identified have submicromolar activity and inhibit both the recombinant proteins and human NAT1 in ZR-75 cell lysates in a competitive manner. H-1 NMR studies on purified mouse Nat2 demonstrate that the inhibitors bind within the putative active site of the enzyme. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2008.11.032

文献信息

• OMAR M. T.; SHERIF F. A., J. PRAKT. CHEM., 1980, 322, NO 5, 835-842
  作者：OMAR M. T.、 SHERIF F. A.

  DOI：——

  日期：——
• CHEMILUMINESCENT COMPOSITIONS, METHODS, ASSAYS AND KITS FOR OXIDATIVE ENZYMES
  申请人：LIFE TECHNOLOGIES CORPORATION

  公开号：US20170137862A1

  公开（公告）日：2017-05-18

  Chemiluminescent compositions, methods, assays and kits for oxidative enzymes are described. Further disclosed are dioxetane compounds of the form: where R can independently be any branched alkyl or cycloalkyl group which provides stabilization for the dioxetane or where both R groups together form a cycloalkyl or polycycloalkyl moiety spiro bound to the dioxetane ring, wherein each R group or the spiro bound moiety can be unsubstituted or substituted with one or more electron-withdrawing groups or electron donating groups, or groups providing preferential oxidative isozyme substrate recognition, and wherein R 1 is an aryl group, or an alkyl group of 1-20 carbon atoms, which can be optionally substituted with 1 or more halogen atoms, and wherein T is an aryl or heteroaryl ring capable of emitting light upon enzyme activated decomposition of the dioxetane I. Kits, methods and assays are also disclosed that comprise the dioxetane compounds.